Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.
Sophia Genetics and Memorial Sloan Kettering Cancer Center have partnered to develop a precision oncology hub focused on multimodal approaches. The collaboration aims to advance diagnostic and treatment strategies in oncology through combined expertise in genetic analysis and clinical care.
Cordica Medical, a medical device contract development and manufacturing organization, has acquired RapidWerks' micro-molding capabilities. The acquisition expands Cordica's precision manufacturing capacity for miniaturized medical devices, adding dedicated automated micro-molding for mass production to its integrated design and manufacturing services.
CereVasc closed an $85 million Series C funding round to support development of its eShunt system, a minimally invasive alternative to conventional brain shunt surgery for hydrocephalus treatment. The company expects to complete a pivotal clinical trial and submit to the FDA in 2027.
CereVasc raised $85 million to advance development of eShunt, an implantable system for treating normal pressure hydrocephalus through cerebrospinal fluid drainage. The funding supports clinical advancement and commercialization of the device.
ResMed completed its acquisition of Noctrix Health for $340 million. Noctrix's lead product, Nidra, is a neuromodulation device targeting peroneal nerves to treat restless leg syndrome symptoms. The deal expands ResMed's portfolio in sleep and respiratory care.
Novellia raised $18 million in Series A funding to expand its real-world data platform, which enables patients to consolidate medical records and share anonymized data with pharmaceutical companies. The platform aims to improve drug research by sourcing more complete healthcare datasets directly from patient sources.
Elation Health acquired Aster, an EHR startup focused on women's health, to expand its AI-enabled electronic health record capabilities. Elation, a California-based supplier of cloud-based clinical EHRs, telehealth services, and practice management software for primary care providers, added Aster's women's health specialization to its existing portfolio of digital tools for healthcare providers.
Subtle Medical closed a $33 million Series C funding round and appointed industry veteran Ohad Arazi as CEO to lead global commercialization of its AI imaging software. The company develops artificial-intelligence tools for medical image processing and analysis.
Veritas Aortic Solutions secured $12 million in funding to advance its technology for treating acute aortic root and ascending aorta pathologies without open heart surgery. The company is developing a minimally invasive approach to address aortic disease, positioning itself as an alternative to conventional surgical intervention.
Countable Labs closed a $26 million funding round to advance its PCR technology platform, which the company claims delivers at least tenfold sensitivity improvement over conventional PCR. The capital will support product development and commercialization of the diagnostic tool.
Amazon appointed Dr. Roy Schoenberg, founder of Amwell, as senior vice president of its Health Services division. Separately, Walmart integrated Teladoc Health services into its Better Care Services platform to expand customer access to third-party providers. GoodRx launched a new subscription service for generic medications.
AstraZeneca and Roche Diagnostics Asia Pacific signed a three-year memorandum of understanding to promote AI-powered digital pathology and biomarker testing for breast and lung cancer across nine Asian markets. The partnership aims to expand adoption of digital pathology solutions in the region.
Walmart and Teladoc Health announced a partnership integrating Teladoc's virtual care services into Walmart's Better Care Services platform, expanding access to remote clinical consultations through the retail giant's existing consumer base and healthcare infrastructure.
Signos, which makes an over-the-counter glucose monitoring system marketed for weight management, raised $20 million in funding from Dexcom, Google Ventures, and Blue Cross Blue Shield of Alabama. The funding round includes a partnership with Dexcom that will make Signos available through Dexcom's direct-to-consumer continuous glucose monitoring website.
Oura, maker of smart rings for health monitoring, has filed for an initial public offering as it expands beyond sleep tracking into broader healthcare applications. The move signals the company's shift from consumer wellness toward clinical-grade monitoring and reflects growing investor appetite for wearable health-tech vendors.
Healthcare engagement platform Swoop has acquired prescription management platform Nimble to expand its pharmacy connectivity and medication fulfillment capabilities. The acquisition adds pharmacy integration services to Swoop's omnichannel marketing and engagement platform for life sciences vendors and healthcare providers.
Olympus has agreed to acquire BioProtect for $270 million to expand its prostate cancer treatment portfolio. BioProtect's primary product is a tissue-protection spacer system used during radiation therapy for prostate cancer. The acquisition strengthens Olympus's specialty medical and oncology device offerings.
Align Technology announced a $200 million investment to build a new manufacturing facility in Hyderabad, India, scheduled to open in 2027. The expansion marks the company's strategy to diversify production capacity and strengthen its supply chain in the Asia-Pacific region.
Innovaccer acquired CaduceusHealth for $66 million to expand its revenue cycle management platform with enhanced capabilities for addressing claim denials. The deal adds agentic AI functionality to Innovaccer's RCM offerings, targeting a key pain point for healthcare providers managing high denial rates.
Oura, maker of the Oura Ring wearable health device, is planning an initial public offering following a $900 million funding round completed in October 2025 that valued the company at $11 billion. The IPO announcement reflects growing investor interest in consumer-facing medtech platforms and wearable health monitoring.
Oura, maker of health-tracking rings, has confidentially filed for an initial public offering with the SEC, seven months after closing a $900 million funding round that valued the company at approximately $11 billion. The filing follows reported strong revenue growth for the Finnish-American wearable vendor.
Neurosoft Bioelectronics has raised $7.5 million in funding to support clinical trials and US commercialisation of its brain-computer interface (BCI) technology. The capital will advance the company's development and regulatory pathway for its neurotechnology platform.
Medtronic announced an agreement to acquire SPR Therapeutics for approximately $650 million in upfront cash. The deal expands Medtronic's chronic pain treatment portfolio, adding SPR's neuromodulation and pain-management technologies to the company's existing offerings in that therapeutic area.
Neurosoft Bioelectronics closed a $7.5 million seed funding round led by Skybound Venture Capital, bringing total funding to over $20 million. The company is developing minimally invasive brain-computer interface technology. The round was oversubscribed and included participation from IAG Capital Partners, Connecticut Innovations, and PL Capital.
Qualtrics completed its $6.75 billion acquisition of Press Ganey Forsta and plans to expand its human-experience-management platform by leveraging what it describes as the largest HX dataset globally. The company intends to integrate AI capabilities to shift experience management from reactive measurement to predictive analytics across industries, including healthcare applications focused on anticipating patient needs and aligning delivery with consumer expectations.
Cagent Vascular raised $41 million in funding to advance its Serranator SONIC intravascular lithotripsy (IVL) system. The capital will support completion of a pivotal clinical trial and commercial readiness for the dual-modality platform, which combines sonic and mechanical energy to treat calcified lesions in coronary and peripheral vessels.
Endologix acquired the Pounce mechanical thrombectomy system from Surmodics, expanding its vascular intervention product portfolio. The acquisition adds a minimally invasive clot-removal device to Endologix's existing vascular and endovascular offerings.
Alcidion, an ASX-listed vendor, has agreed to acquire Telstra Health's Kyra patient flow solutions suite, which includes Kyra Patient Flow Manager, Kyra Queue Manager, and Kyra IQ. The acquisition expands Alcidion's enterprise patient flow software across Australia. Kyra products support inpatient and outpatient workflows including bed management, patient check-ins, wayfinding, referral management, triage, billing, data consolidation, and operational reporting.
AP Technologies acquired Blueacre Technology, an Ireland-based specialist in laser micromachining and nitinol processing for medical devices. The deal establishes AP Technologies' first European operation and expands its catheter platform to include laser-processed metallic components for minimally invasive surgical devices.
Brian Miller, former executive vice president and chief digital officer at Intuitive Surgical, has joined Sovato as CEO. Miller spent a long career at Intuitive, the leading surgical robotics company, and is now leading Sovato's efforts to scale telesurgery platforms. The move reflects executive-level shifts in the surgical robotics and digital surgery sector.
Commure, an AI-enabled healthcare software company, raised $70 million in Series D funding led by General Catalyst, bringing total funding to $750 million and post-money valuation to $7 billion. The company and its subsidiary Athelas provide AI tools to help healthcare providers with administrative workflows.
Boston Scientific announced a $1.5 billion investment to acquire a 34% equity stake in MiRus, a developer of implants and procedural solutions. The investment underscores Boston Scientific's strategy to expand its portfolio in implantable devices and minimally invasive procedural technologies.
Acute care electronic health record purchasing activity declined sharply in 2025 as health systems deferred major platform decisions due to economic pressure, policy uncertainty, and increased investment in AI technologies. Epic expanded its market share during the slowdown in overall EHR procurement.
Artivion has completed a $135 million acquisition of Endospan following US regulatory approval of Nexus, an endovascular device for aortic arch syndrome treatment. The deal, structured under a 2019 agreement, expands Artivion's portfolio in the aortic intervention space and adds Endospan's technology platform to its surgical and interventional cardiology offerings.
Embecta completed its acquisition of UK-based Owen Mumford Holdings for $172.6 million. Owen Mumford is a medical device manufacturer whose product portfolio spans injection devices, diagnostic sampling systems, and drug delivery solutions. The deal expands Embecta's capabilities in patient-centric device design and drug delivery platforms.
IKS Health has acquired healthcare AI startup ARAI to expand its automation technology capabilities and reduce reliance on third-party AI models. The acquisition strengthens IKS Health's proprietary AI infrastructure for its automation tools used across healthcare operations.
9amHealth, a virtual specialty care platform focused on cardiometabolic health, closed a $26 million Series B round led by Define Ventures, with participation from SemperVirens, Catalio Capital Management, and NewHealth Ventures. The funding will support platform growth and enhancement. Define Ventures' founder will join the board.
Butterfly Medical closed a $21 million Series C funding round to advance development and commercialization of its minimally invasive benign prostatic hyperplasia (BPH) treatment device. The funding supports the company's effort to bring the urology-focused technology to market.
BlueWind Medical closed a $47.8 million funding round to accelerate commercialisation of its Revi implantable tibial neuromodulation system for urge urinary incontinence treatment. Proceeds will fund expanded sales operations and market access initiatives.
Ardent Health, an acute care hospital operator across six US states, has partnered with Fujifilm Healthcare to deploy Synapse enterprise imaging solutions across its facilities. Synapse is an enterprise platform for managing medical imaging data and workflows across health systems.
45 older market stories available.